Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0755
D

Failure to Ensure Proper Return and Accountability of Controlled Substances

Morganton, North Carolina Survey Completed on 12-19-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to maintain effective systems for the return of controlled medications to the pharmacy for three residents who had discontinued narcotic prescriptions. For each resident, there were discrepancies between the controlled substance count records and the medication administration records (MARs), as well as inconsistencies in the documentation of medication returns. In one case, a resident prescribed hydrocodone-acetaminophen had 10 tablets remaining after discontinuation, and the return of drugs form was completed, but the medication was not received by the pharmacy. Similarly, another resident prescribed oxycodone had 17 tablets left, and a third resident prescribed oxycodone-acetaminophen had 30 tablets remaining; both medications were documented as prepared for return, but the pharmacy did not receive them. The investigation revealed that the process for returning controlled substances involved placing discontinued medications in an unsealed bag in the narcotic drawer, completing a return of drug form, and faxing the form to the pharmacy. However, there was confusion and lack of clarity among staff regarding who completed the forms and who was responsible for ensuring the medications were picked up by the pharmacy courier. The return of drug form for the missing medications was found with a courier signature that was later determined not to be authentic. Staff interviews indicated that while the medications were prepared for return and placed in the appropriate location, there was no confirmation that the pharmacy courier actually picked up the medications, and the medications were ultimately unaccounted for. The pharmacy manager confirmed that the pharmacy had no record of receiving the medications or the return of drug form, and the courier verified that the signature on the form was not hers. The facility's internal investigation, including interviews with nursing staff and audits of medication carts, was unable to determine the exact circumstances of the missing medications. The deficiency was attributed to the facility's failure to have a reliable system for verifying and documenting the return of controlled substances, resulting in unaccounted-for narcotic medications.

An unhandled error has occurred. Reload 🗙